Adicet bio to participate in stifel 2021 virtual healthcare conference

Menlo park, calif., nov. 08, 2021 (globe newswire) -- adicet bio, inc. (nasdaq: acet), a biotechnology company discovering and developing first-in-class allogeneic gamma delta t cell therapies for cancer and other diseases, today announced that chen schor, president and chief executive officer, will present at the stifel 2021 virtual healthcare conference taking place on november 15-17, 2021.
ACET Ratings Summary
ACET Quant Ranking